Drugs Approved by the FDA

The following information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company: Duract, Wyeth-Ayerst Laboratories
Approval Status: Approved July 1997
Treatment for: acute pain

General Information

Bromfenac was cleared for marketing by the FDA on July 15, 1997. This provides an alternative to opioids for the management of acute pain. Bromfenac provides fast relief of acute pain without the side effects of opioid analgesics.

Side Effects

Possible adverse side effects include abdominal pain, headache, nausea, and vomiting.